Department of Urology, Seoul National University College of Medicine, Seoul, Korea.
Urology. 2010 Jun;75(6):1460-6. doi: 10.1016/j.urology.2009.09.065. Epub 2009 Dec 6.
To investigate whether the presence of detrusor overactivity (DO) influences storage symptoms after photoselective laser vaporization of the prostate (PVP) for benign prostatic hyperplasia (BPH).
A total of 149 patients who underwent PVP were included in this retrospective study. All patients underwent a preoperative evaluation including multichannel video urodynamics. The efficacy of the PVP was assessed at 1, 3, 6, and 12 months postoperatively using the International Prostate Symptom Score (IPSS), uroflowmetry, postvoid residual urine volume, and 3-day frequency-volume charts (FVC). The patients were stratified into 2 groups (DO group vs non-DO group).
The IPSS and FVC showed that the storage symptoms were reduced significantly after the PVP in both groups (P<.05). Starting from 6 months after the PVP, the DO group (n=39) showed a significantly greater reduction in the subtotal storage symptom score than the non-DO group (n=110). When the improvement of storage symptoms was defined as a reduction of >or=50% in the subtotal storage symptom scores, the percentage of patients with improvement in the storage symptoms at 1, 3, 6, and 12 months after the PVP was 13.9%, 25.9%, 47.8%, and 52.9% in the DO group, and 22.2%, 24.4%, 33.3%, and 33.3% in the non-DO group, respectively.
Our results show that storage and voiding symptoms significantly improved after the PVP. In addition, we found that men with DO might show more improvement of storage symptoms, after the PVP, than men without DO.
研究逼尿肌过度活动(DO)是否会影响良性前列腺增生(BPH)经前列腺光选择性激光汽化术(PVP)治疗后的储尿期症状。
本回顾性研究共纳入 149 例行 PVP 的患者。所有患者均接受术前评估,包括多通道视频尿动力学检查。术后 1、3、6 和 12 个月,采用国际前列腺症状评分(IPSS)、尿流率、残余尿量和 3 天频率-容量图(FVC)评估 PVP 的疗效。患者分为 2 组(DO 组和非 DO 组)。
两组患者的 IPSS 和 FVC 均显示术后储尿期症状明显改善(P<.05)。从 PVP 后 6 个月开始,DO 组(n=39)的总储尿期症状评分的降低明显大于非 DO 组(n=110)。将储尿期症状的改善定义为总储尿期症状评分降低≥50%时,PVP 后 1、3、6 和 12 个月,DO 组改善储尿期症状的患者比例分别为 13.9%、25.9%、47.8%和 52.9%,而非 DO 组分别为 22.2%、24.4%、33.3%和 33.3%。
我们的结果表明,PVP 后储尿和排尿症状均显著改善。此外,我们发现与无 DO 者相比,DO 患者 PVP 后储尿期症状的改善可能更为明显。